ILMN

ILMN

USD

Illumina Inc. Common Stock

$121.900+1.690 (1.406%)

Real-time Price

Healthcare
Diagnostics & Research
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$120.210

High

$122.075

Low

$119.360

Volume

1.86M

Company Fundamentals

Market Cap

18.6B

Industry

Diagnostics & Research

Country

United States

Trading Stats

Avg Volume

1.68M

Exchange

NMS

Currency

USD

52-Week Range

Low $68.7Current $121.900High $153.06

AI Analysis Report

Last updated: Nov 3, 2025
AI-GeneratedData Source: Yahoo Finance, Bloomberg, SEC

Illumina (ILMN): Decoding Market Signals Amid Analyst Upgrades and AI Predictions

Price Action Reality Check

After a rocky Q3 that saw the stock bottom out at $91.30 (Sep 25), Illumina exploded higher in late October. The October 31 print of $123.54 marked a 24.7% single-day surge--the largest move since early August. This came on 6.5x average volume, suggesting institutional buying power behind the rally. While the stock now sits 44% above its 52-week low and 24% below its 52-week high, the aggressive jump leaves technical questions about sustainability.

News Sentiment Breakdown

Analysts split on Illumina’s prospects:

  • Evercore ISI (Outperform, $142 target) and UBS (Neutral, $120) highlight bullish extremes
  • Barclays ($100 target) remains cautious amid upgrades
  • Mixed messaging: 21.9% average upside across analyst targets vs. current $123.54 price

The October 30 earnings release appears to be the catalyst for this divergence. Technicals show conflicting signals:

  • Bullish: RSI at

Related News

Analyst Upgrades

Barclays Maintains Underweight on Illumina, Raises Price Target to $100

Barclays analyst Luke Sergott maintains Illumina with a Underweight and raises the price target from $95 to $100.

View more
Barclays Maintains Underweight on Illumina, Raises Price Target to $100
Analyst Upgrades

Canaccord Genuity Maintains Hold on Illumina, Raises Price Target to $112

Canaccord Genuity analyst Kyle Mikson maintains Illumina with a Hold and raises the price target from $105 to $112.

View more
Canaccord Genuity Maintains Hold on Illumina, Raises Price Target to $112
Analyst Upgrades

JP Morgan Maintains Neutral on Illumina, Raises Price Target to $105

JP Morgan analyst Casey Woodring maintains Illumina with a Neutral and raises the price target from $100 to $105.

View more
JP Morgan Maintains Neutral on Illumina, Raises Price Target to $105
Analyst Upgrades

TD Cowen Maintains Hold on Illumina, Raises Price Target to $115

TD Cowen analyst Dan Brennan maintains Illumina with a Hold and raises the price target from $110 to $115.

View more
TD Cowen Maintains Hold on Illumina, Raises Price Target to $115
Analyst Upgrades

UBS Maintains Neutral on Illumina, Raises Price Target to $120

UBS analyst John Sourbeer maintains Illumina with a Neutral and raises the price target from $110 to $120.

View more
UBS Maintains Neutral on Illumina, Raises Price Target to $120
Analyst Upgrades

Evercore ISI Group Maintains Outperform on Illumina, Raises Price Target to $142

Evercore ISI Group analyst Vijay Kumar maintains Illumina with a Outperform and raises the price target from $132 to $142.

PR Newswire

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025

Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the third quarter of fiscal year 2025. "I am...

AI PredictionBeta

AI Recommendation

Bullish

Updated at: Nov 10, 2025, 11:53 AM

BearishNeutralBullish

67.3% Confidence

Risk & Trading

Risk Level3/5
Medium Risk
Suitable For
Conservative
Trading Guide

Entry Point

$121.46

Take Profit

$129.89

Stop Loss

$109.68

Key Factors

PDI 9.3 is above MDI 5.0 with ADX 15.0, suggesting bullish trend
Current Price is extremely close to support level ($121.27), suggesting strong buying opportunity
Trading volume is 4.5x average (17,664), indicating extremely strong buying pressure
MACD 0.1239 is below signal line 0.1247, indicating a bearish crossover

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.